Lv3
294 积分 2023-01-11 加入
Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk
2个月前
已完结
MASLD, MASH, and the CKM Spectrum
3个月前
已关闭
Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study
3个月前
已完结
Long‐term weight maintenance and risk of cardiometabolic multimorbidity and its subtypes in middle‐aged and older adults: A pooled landmark analysis in China and the UK
3个月前
已完结
Some Much-Needed CONFIDENCE to Combat the Risk-Treatment Paradox in Chronic Kidney Disease
3个月前
已关闭
US State-Level Prevalence of Adult Obesity by Race and Ethnicity From 1990 to 2022 and Forecasted to 2035
3个月前
已完结
Underweight and cardiovascular risk in Type 2 diabetes: a Korean nationwide study
3个月前
已完结
Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation
3个月前
已完结
Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation
3个月前
已完结
Target Trial Emulation
3个月前
已完结
皖公网安备34019202002308
